QA: AKORN INC in us_pharma/2019

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0000003116_2020_AKORN_INC.pdf

Logs

warning Missing logo subcommand.report {}
info Failed to set obs_EconomicCapitalRatio industry.us_generic {'reason': "KeyError('0000003116')"}

Graph

Absolute values for 0000003116, AKORN INC

  xvar xval
0 AssetsCurrent 480,047,000
1 IntangibleAssetsNetIncludingGoodwill 483,724,000
2 PropertyPlantAndEquipmentNet 295,533,000
3 remainder_Assets 29,335,000
4 LiabilitiesCurrent 985,587,000
5 LiabilitiesNoncurrent 68,760,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 429,723,000
8 SellingGeneralAndAdministrativeExpense 273,871,000
9 ResearchAndDevelopmentExpense 37,500,000
10 remainder_Expenses 99,942,000
11 remainder_Revenues 682,429,000
12 remainder_NetIncome -68,163,000
13 remainder_ComprehensiveNetIncome -3,772,000
  yvar yval
0 Assets 1,288,639,000
1 Liabilities 1,054,347,000
2 Expenses 841,036,000
3 Revenues 682,429,000
4 StockholdersEquity 234,292,000
5 NetIncome -226,770,000
6 ComprehensiveNetIncome -228,656,000
7 BaseVar 1,969,193,000
8 EconomicCapitalRatio 0.149

Edgar->Model Mapping

Feature Distribution

Change over Time